{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:30:24Z","timestamp":1774438224081,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,12,3]],"date-time":"2008-12-03T00:00:00Z","timestamp":1228262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1136\/ard.2008.099861","type":"journal-article","created":{"date-parts":[[2008,12,4]],"date-time":"2008-12-04T01:26:42Z","timestamp":1228354002000},"page":"1105-1112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":132,"title":["Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"68","author":[{"given":"W","family":"Katchamart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Trudeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Phumethum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Bombardier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2008.099861_bib1","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/S0140-6736(98)08513-4","article-title":"Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial","volume":"353","author":"M\u00f6tt\u00f6nen","year":"1999","journal-title":"Lancet"},{"key":"10.1136\/ard.2008.099861_bib2","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1002\/art.21405","article-title":"Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial","volume":"52","author":"Goekoop-Ruiterman","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.099861_bib3","doi-asserted-by":"crossref","first-page":"406","DOI":"10.7326\/0003-4819-146-6-200703200-00005","article-title":"Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial","volume":"146","author":"Goekoop-Ruiterman","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2008.099861_bib4","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/rheumatology\/keg394","article-title":"Radiographic progression in early rheumatoid arthritis: a 12-month randomized controlled study comparing the combination of cyclosporin and methotrexate with methotrexate alone","volume":"42","author":"Marchesoni","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2008.099861_bib5","first-page":"142","article-title":"Comparison of low dose methotrexate and combination therapy with methotrexate and sulphasalazine in the treatment of early rheumatoid arthritis","volume":"14","author":"Tascioglu","year":"2003","journal-title":"J Rheumatol Med Rehab"},{"key":"10.1136\/ard.2008.099861_bib6","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/ard.58.4.220","article-title":"Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components","volume":"58","author":"Dougados","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.099861_bib7","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1136\/ard.2008.094474","volume":"68","author":"Visser","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.099861_bib8","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/art.1780360601","article-title":"The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials","volume":"36","author":"Felson","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.099861_bib9","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/art.1780380602","article-title":"American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis","volume":"38","author":"Felson","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.099861_bib10","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/art.1780241012","article-title":"Preliminary criteria for clinical remission in rheumatoid arthritis","volume":"24","author":"Pinals","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.099861_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/ard.51.2.177","article-title":"Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis","volume":"51","author":"van der Heijde","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.099861_bib12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.099861_bib13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/art.1780390105","volume":"39","author":"van Gestel","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.099861_bib14","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1097\/01.BRS.0000065484.95996.AF","article-title":"The Editorial Board of the Cochrane Collaboration Back Review G. Updated method guidelines for systematic reviews in the Cochrane collaboration back review group","volume":"28","author":"van Tulder","year":"2003","journal-title":"Spine"},{"key":"10.1136\/ard.2008.099861_bib15","unstructured":"Alderson P, Green S. Meta-analysis of continuous data: deciding on a change (from baseline). Cochrane Collaboration: Open learning material for reviewers, 2002. Available at http:\/\/www.cochrane-net.org\/openlearning\/HTML\/mod0.htm (additional module A1, accessed 16 April 2009)."},{"key":"10.1136\/ard.2008.099861_bib16","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/rheumatology\/36.10.1082","article-title":"Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial","volume":"36","author":"Haagsma","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.2008.099861_bib17","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/art.21796","volume":"54","author":"Hetland","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.099861_bib18","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/art.21620","article-title":"Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone","volume":"54","author":"O\u2019Dell","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.099861_bib19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJM199507203330301","article-title":"Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group","volume":"333","author":"Tugwell","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2008.099861_bib20","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7326\/0003-4819-137-9-200211050-00007","article-title":"Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial","volume":"137","author":"Kremer","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2008.099861_bib21","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/art.21018","article-title":"A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study","volume":"52","author":"Lehman","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.099861_bib22","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/art.21824","article-title":"Preliminary evidence for a structural benefit of the new bisphosphonate zoledronic acid in early rheumatoid arthritis","volume":"54","author":"Jarrett","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.099861_bib23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/01.smj.0000254190.54327.3b","article-title":"Levofloxacin treatment in patients with rheumatoid arthritis receiving methotrexate","volume":"100","author":"Ogrendik","year":"2007","journal-title":"South Med J"},{"key":"10.1136\/ard.2008.099861_bib24","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/art.1780350802","article-title":"Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial","volume":"35","author":"Willkens","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.099861_bib25","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/art.1780381213","article-title":"Comparison of azathioprine, methotrexate, and the combination of the two in the treatment of rheumatoid arthritis. A forty-eight-week controlled clinical trial with radiologic outcome assessment","volume":"38","author":"Willkens","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.099861_bib26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/03009749409103721","article-title":"Combination therapy with methotrexate and chloroquine in rheumatoid arthritis. A multicenter randomized placebo-controlled trial","volume":"23","author":"Ferraz","year":"1994","journal-title":"Scand J Rheumatol"},{"key":"10.1136\/ard.2008.099861_bib27","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/rheumatology\/33.11.1049","article-title":"Combination of methotrexate and sulphasalazine vs methotrexate alone: a randomized open clinical trial in rheumatoid arthritis patients resistant to sulphasalazine therapy","volume":"33","author":"Haagsma","year":"1994","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.2008.099861_bib28","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJM199605163342002","article-title":"Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications","volume":"334","author":"O\u2019Dell","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2008.099861_bib29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/BF03041257","article-title":"Long-term methotrexate (MTX) combination therapy versus MTX alone for active rheumatoid arthritis","volume":"9","author":"Hanyu","year":"1999","journal-title":"Jpn J Rheumatol"},{"key":"10.1136\/ard.2008.099861_bib30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/s10165-005-0420-z","article-title":"Therapeutic effects of the combination of methotrexate and bucillamine in early rheumatoid arthritis: a multicenter, double-blind, randomized controlled study","volume":"15","author":"Ichikawa","year":"2005","journal-title":"Mod Rheumatol"},{"key":"10.1136\/ard.2008.099861_bib31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/ard.2006.057133","article-title":"Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study","volume":"66","author":"Capell","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.099861_bib32","first-page":"1","article-title":"Efficacy of sulphasalazine plus methotrexate in rheumatoid arthritis","volume":"26","author":"Islam","year":"2000","journal-title":"Bangladesh Med Res Counc Bull"},{"key":"10.1136\/ard.2008.099861_bib33","first-page":"72","article-title":"Efficacy of triple DMARD therapy in patients with RA with suboptimal response to methotrexate","volume":"44","author":"O\u2019Dell","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2008.099861_bib34","doi-asserted-by":"crossref","first-page":"124","DOI":"10.7326\/0003-4819-148-2-200801150-00192","article-title":"Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis","volume":"148","author":"Donahue","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2008.099861_bib35","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/rheumatology\/37.6.612","article-title":"Combination therapy in rheumatoid arthritis: updated systematic review","volume":"37","author":"Verhoeven","year":"1998","journal-title":"Br Rheumatol"},{"key":"10.1136\/ard.2008.099861_bib36","doi-asserted-by":"crossref","first-page":"iii51","DOI":"10.1136\/ard.60.90003.iii51","article-title":"'Stepping-up\u2019 from methotrexate: a systematic review of randomised placebo controlled trials in patients with rheumatoid arthritis with an incomplete response to methotrexate","volume":"60","author":"Hochberg","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.099861_bib37","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/art.1780371012","article-title":"The efficacy and toxicity of combination therapy in rheumatoid arthritis: A meta-analysis","volume":"37","author":"Felson","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.099861_bib38","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1093\/rheumatology\/kei031","article-title":"A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal","volume":"44","author":"Choy","year":"2005","journal-title":"Rheumatology (Oxford)"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724217106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724217106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2008.099861","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T08:49:52Z","timestamp":1739522992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724217106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0003496724217106"],"URL":"https:\/\/doi.org\/10.1136\/ard.2008.099861","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2008.099861","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 \u00a9 Katchamart et al 2009, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}